DS
IDYA icon

David Shaw’s IDEAYA Biosciences IDYA Stock Holding History

David Shaw’s Portfolio IDYA Stock Details IDYA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$774K Buy
+20,763
New +$636K ﹤0.01% 3926
2025
Q3 		– Sell
-98,153
Closed -$2.06M – 4728
2025
Q2 		$2.06M Sell
98,153
-210,403
-68% -$4.04M ﹤0.01% 2723
2025
Q1 		$5.05M Buy
308,556
+127,880
+71% +$2.72M ﹤0.01% 1881
2024
Q4 		$4.64M Sell
180,676
-387,055
-68% -$11M ﹤0.01% 2042
2024
Q3 		$18M Sell
567,731
-316,807
-36% -$12M 0.02% 1045
2024
Q2 		$31.1M Buy
884,538
+226,514
+34% +$8.97M 0.03% 655
2024
Q1 		$28.9M Buy
658,024
+128,518
+24% +$5.53M 0.02% 712
2023
Q4 		$18.8M Buy
529,506
+93,148
+21% +$2.78M 0.02% 963
2023
Q3 		$11.8M Buy
436,358
+223,143
+105% +$5.66M 0.01% 1174
2023
Q2 		$5.01M Buy
213,215
+116,156
+120% +$2.39M 0.01% 1853
2023
Q1 		$1.33M Buy
97,059
+76,118
+363% +$1.27M ﹤0.01% 2965
2022
Q4 		$380K Buy
+20,941
New +$352K ﹤0.01% 3987
2022
Q2 		– Sell
-24,590
Closed -$275K – 5520
2022
Q1 		$275K Sell
24,590
-22,927
-48% -$338K ﹤0.01% 4702
2021
Q4 		$1.12M Buy
47,517
+27,710
+140% +$644K ﹤0.01% 3834
2021
Q3 		$505K Buy
+19,807
New +$462K ﹤0.01% 4079
2021
Q2 		– Sell
-19,293
Closed -$453K – 4861
2021
Q1 		$453K Sell
19,293
-9,904
-34% -$191K ﹤0.01% 3549
2020
Q4 		$409K Buy
+29,197
New +$396K ﹤0.01% 3481

Other funds holding IDYA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
LGM
Logos Global Management San Francisco, California $2.32B AUM 536.01% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return

David Shaw's IDYA Position: Q2 2026 in Review

David Shaw opened a new position in IDEAYA Biosciences (IDYA) in Q2 2026: 20,763 shares worth $774K. The stake represents ﹤0.01% of the portfolio and ranks #3926 among its holdings. This is a return to the name: David Shaw previously reported a position in IDYA as recently as Q2 2025.

David Shaw first reported a position in IDYA in Q4 2020 and has held it in 17 quarters since. The position peaked at $31.1M in Q2 2024. 282 funds tracked by Wall St. Rank hold IDYA as of Q2 2026.

  • David Shaw held 20,763 shares of IDEAYA Biosciences worth $774K as of Q2 2026.
  • IDEAYA Biosciences was a new David Shaw position in Q2 2026.
  • IDEAYA Biosciences made up ﹤0.01% of David Shaw's portfolio in Q2 2026, its #3926 holding.
  • David Shaw first reported a position in IDEAYA Biosciences in Q4 2020 and has held it in 17 quarters since.
  • David Shaw's IDEAYA Biosciences position peaked at $31.1M in Q2 2024.
  • 282 funds tracked by Wall St. Rank held IDEAYA Biosciences as of Q2 2026.

Based on D.E. Shaw & Co's 13F filing for Q2 2026, filed 14 Aug 2026.